Most recently, she served as chief human resources officer at Vyripharm Enterprises.
MEI Pharma, a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced that Anne Frese, an experienced industry executive, joined MEI as chief people officer, a role reporting to Daniel P. Gold, chief executive officer. Frese will be responsible for the strategy and processes related to building and retaining an exceptional team of professionals. Frese’s appointment is effective immediately.
Frese joins MEI with over 30 years of human resource experience across a variety of industries, including biotech, consulting, hospitality, and engineering. Most recently, she served as chief human resources officer at Vyripharm Enterprises. Previously, Frese’s experience includes serving as Vice President of Human Resources at Artiva Therapeutics and Bellicum Pharmaceuticals, Inc. She received a bachelor's degree in Labor Relations and Economics from the McGill University.
“Anne is a highly experienced and skilled leader with a talent for building organizations and high-performance teams,” said Dan Gold, chief executive officer at MEI Pharma. “In her new role, Anne will support the development of our teams, processes, and operations by drawing on her passion for people. On behalf of our leadership team, I welcome Anne and look forward to working with her.”
“I am excited to join MEI and look forward to supporting the continued growth of the organization. MEI’s leadership team is deeply committed to fostering a collaborative culture, in which the team is connected to a mission of making a meaningful impact in patient lives,” said Frese.
Subscribe To Our Newsletter & Stay Updated